{"transactions":[{"id":717460,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-02T20:46:40.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1869,"price":2.66,"value":4971.54,"ownership":{"direct":true},"balance_after":58823,"source":{"system":"sec-edgar","filing":"0001372514-26-000065","document":"wk-form4_1783025197.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000065/wk-form4_1783025197.xml","form_type":"4"}},{"id":819095,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-04-02T20:45:32.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1906,"price":1.95,"value":3716.7,"ownership":{"direct":true},"balance_after":60692,"source":{"system":"sec-edgar","filing":"0001372514-26-000030","document":"wk-form4_1775162730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000030/wk-form4_1775162730.xml","form_type":"4"}},{"id":850465,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T20:36:52.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":33467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2027, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":33467,"derivative":{"exercise_price":1.98,"exercise_date":"2027-04-01","expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":33467},"source":{"system":"sec-edgar","filing":"0001372514-26-000013","document":"wk-form4_1773175009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000013/wk-form4_1773175009.xml","form_type":"4"}},{"id":850464,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-10T20:36:52.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":16733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":62598,"source":{"system":"sec-edgar","filing":"0001372514-26-000013","document":"wk-form4_1773175009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000013/wk-form4_1773175009.xml","form_type":"4"}},{"id":855587,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-06T19:03:29.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":238,"price":2.02,"value":480.76,"ownership":{"direct":true},"balance_after":45865,"source":{"system":"sec-edgar","filing":"0001372514-26-000006","document":"wk-form4_1772823806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000006/wk-form4_1772823806.xml","form_type":"4"}},{"id":1182819,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:28:23.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":31883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2026, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":31883,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":31883},"source":{"system":"sec-edgar","filing":"0001372514-25-000034","document":"wk-form4_1743640097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000034/wk-form4_1743640097.xml","form_type":"4"}},{"id":1182818,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-03T00:28:23.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":15941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":46103,"source":{"system":"sec-edgar","filing":"0001372514-25-000034","document":"wk-form4_1743640097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000034/wk-form4_1743640097.xml","form_type":"4"}},{"id":1459513,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:16:52.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":31259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 1, 2025, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":31259,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":31259},"source":{"system":"sec-edgar","filing":"0001372514-24-000097","document":"wk-form4_1720034205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000097/wk-form4_1720034205.xml","form_type":"4"}},{"id":1459512,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T19:16:52.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":15629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of July 1, 2025, July 1, 2026 and July 1, 2027, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":30160,"source":{"system":"sec-edgar","filing":"0001372514-24-000097","document":"wk-form4_1720034205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000097/wk-form4_1720034205.xml","form_type":"4"}},{"id":1480300,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-06-13T19:49:44.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":4.999,"value":14997.0,"ownership":{"direct":true},"balance_after":14531,"source":{"system":"sec-edgar","filing":"0001372514-24-000060","document":"wk-form4_1718308174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000060/wk-form4_1718308174.xml","form_type":"4"}},{"id":1766714,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T20:47:26.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":0.5677,"exercise_date":"2023-09-29","expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001372514-23-000148","document":"wk-form4_1696366025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000148/wk-form4_1696366025.xml","form_type":"4"}},{"id":1766713,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-10-03T20:47:26.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":103783,"source":{"system":"sec-edgar","filing":"0001372514-23-000148","document":"wk-form4_1696366025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000148/wk-form4_1696366025.xml","form_type":"4"}},{"id":1965227,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T01:15:04.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":10400,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":10400},"source":{"system":"sec-edgar","filing":"0001372514-23-000035","document":"wf-form4_167823809348747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000035/wf-form4_167823809348747.xml","form_type":"4"}},{"id":1965226,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-08T01:15:04.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":15600,"price":3.83,"value":59748.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":28783,"source":{"system":"sec-edgar","filing":"0001372514-23-000035","document":"wf-form4_167823809348747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000035/wf-form4_167823809348747.xml","form_type":"4"}},{"id":2132225,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-25T21:30:34.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":18750,"derivative":{"exercise_price":6.78,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001104659-22-111239","document":"tm2228925-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922111239/tm2228925-1_4seq1.xml","form_type":"4"}},{"id":2132224,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-25T21:30:34.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of October 21, 2023, October 21, 2024 and October 21, 2025, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":13183,"source":{"system":"sec-edgar","filing":"0001104659-22-111239","document":"tm2228925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922111239/tm2228925-1_4seq1.xml","form_type":"4"}},{"id":2413134,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T00:01:37.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":75000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-22-011491","document":"tm225348d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922011491/tm225348d2_4.xml","form_type":"4"}},{"id":2500256,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T21:35:41.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":17853,"price":1.41,"value":25172.73,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.41, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":27370,"source":{"system":"sec-edgar","filing":"0001104659-21-142537","document":"tm2133588-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921142537/tm2133588-1_4seq1.xml","form_type":"4"}},{"id":2500255,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T21:35:41.000Z","date":"2021-10-21","kind":"grant","acquired":true,"shares":9517,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021."}],"balance_after":9517,"source":{"system":"sec-edgar","filing":"0001104659-21-142537","document":"tm2133588-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921142537/tm2133588-1_4seq1.xml","form_type":"4"}},{"id":2619762,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-02T21:30:52.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 26, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":100000,"derivative":{"exercise_price":3.12,"expiration_date":"2031-07-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-098991","document":"tm2123223d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921098991/tm2123223d1_4.xml","form_type":"4"}}]}